135 related articles for article (PubMed ID: 17579659)
1. [11C]Flumazenil PET in temporal lobe epilepsy: do we need an arterial input function or kinetic modeling?
Hammers A; Panagoda P; Heckemann RA; Kelsch W; Turkheimer FE; Brooks DJ; Duncan JS; Koepp MJ
J Cereb Blood Flow Metab; 2008 Jan; 28(1):207-16. PubMed ID: 17579659
[TBL] [Abstract][Full Text] [Related]
2. Regional hippocampal [11C]flumazenil PET in temporal lobe epilepsy with unilateral and bilateral hippocampal sclerosis.
Koepp MJ; Labbé C; Richardson MP; Brooks DJ; Van Paesschen W; Cunningham VJ; Duncan JS
Brain; 1997 Oct; 120 ( Pt 10)():1865-76. PubMed ID: 9365376
[TBL] [Abstract][Full Text] [Related]
3. 11C-flumazenil PET in patients with refractory temporal lobe epilepsy and normal MRI.
Koepp MJ; Hammers A; Labbé C; Woermann FG; Brooks DJ; Duncan JS
Neurology; 2000 Jan; 54(2):332-9. PubMed ID: 10668692
[TBL] [Abstract][Full Text] [Related]
4. 18F-flumazenil: a γ-aminobutyric acid A-specific PET radiotracer for the localization of drug-resistant temporal lobe epilepsy.
Vivash L; Gregoire MC; Lau EW; Ware RE; Binns D; Roselt P; Bouilleret V; Myers DE; Cook MJ; Hicks RJ; O'Brien TJ
J Nucl Med; 2013 Aug; 54(8):1270-7. PubMed ID: 23857513
[TBL] [Abstract][Full Text] [Related]
5. In vivo [11C]flumazenil-PET correlates with ex vivo [3H]flumazenil autoradiography in hippocampal sclerosis.
Koepp MJ; Hand KS; Labbé C; Richardson MP; Van Paesschen W; Baird VH; Cunningham VJ; Bowery NG; Brooks DJ; Duncan JS
Ann Neurol; 1998 May; 43(5):618-26. PubMed ID: 9585356
[TBL] [Abstract][Full Text] [Related]
6. 11C-flumazenil PET, volumetric MRI, and quantitative pathology in mesial temporal lobe epilepsy.
Koepp MJ; Richardson MP; Labbé C; Brooks DJ; Cunningham VJ; Ashburner J; Van Paesschen W; Revesz T; Duncan JS
Neurology; 1997 Sep; 49(3):764-73. PubMed ID: 9305338
[TBL] [Abstract][Full Text] [Related]
7. Glucose and [11C]flumazenil positron emission tomography abnormalities of thalamic nuclei in temporal lobe epilepsy.
Juhász C; Nagy F; Watson C; da Silva EA; Muzik O; Chugani DC; Shah J; Chugani HT
Neurology; 1999 Dec; 53(9):2037-45. PubMed ID: 10599778
[TBL] [Abstract][Full Text] [Related]
8. Abnormalities of grey and white matter [11C]flumazenil binding in temporal lobe epilepsy with normal MRI.
Hammers A; Koepp MJ; Hurlemann R; Thom M; Richardson MP; Brooks DJ; Duncan JS
Brain; 2002 Oct; 125(Pt 10):2257-71. PubMed ID: 12244083
[TBL] [Abstract][Full Text] [Related]
9. Advanced [(18)F]FDG and [(11)C]flumazenil PET analysis for individual outcome prediction after temporal lobe epilepsy surgery for hippocampal sclerosis.
Yankam Njiwa J; Gray KR; Costes N; Mauguiere F; Ryvlin P; Hammers A
Neuroimage Clin; 2015; 7():122-31. PubMed ID: 25610774
[TBL] [Abstract][Full Text] [Related]
10. MRI-guided flumazenil- and FDG-PET in temporal lobe epilepsy.
Szelies B; Weber-Luxenburger G; Pawlik G; Kessler J; Holthoff V; Mielke R; Herholz K; Bauer B; Wienhard K; Heiss WD
Neuroimage; 1996 Apr; 3(2):109-18. PubMed ID: 9345482
[TBL] [Abstract][Full Text] [Related]
11. Periventricular white matter flumazenil binding and postoperative outcome in hippocampal sclerosis.
Hammers A; Koepp MJ; Brooks DJ; Duncan JS
Epilepsia; 2005 Jun; 46(6):944-8. PubMed ID: 15946336
[TBL] [Abstract][Full Text] [Related]
12. Neocortical abnormalities of [11C]-flumazenil PET in mesial temporal lobe epilepsy.
Hammers A; Koepp MJ; Labbé C; Brooks DJ; Thom M; Cunningham VJ; Duncan JS
Neurology; 2001 Apr; 56(7):897-906. PubMed ID: 11294927
[TBL] [Abstract][Full Text] [Related]
13. [11 C]Flumazenil binding in the medial temporal lobe in patients with temporal lobe epilepsy: correlation with hippocampal MR volumetry, T2 relaxometry, and neuropathology.
Lamusuo S; Pitkänen A; Jutila L; Ylinen A; Partanen K; Kälviäinen R; Ruottinen HM; Oikonen V; Någren K; Lehikoinen P; Vapalahti M; Vainio P; Rinne JO
Neurology; 2000 Jun; 54(12):2252-60. PubMed ID: 10881249
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of 11C-flumazenil positron emission tomography in intractable temporal lobe epilepsy.
Padma MV; Simkins R; White P; Satter M; Christian BT; Dunigan K; Lee C; Jacobs M; Mukherjee J; Mantil JC
Neurol India; 2004 Dec; 52(4):457-62. PubMed ID: 15626833
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Performance of Positron Emission Tomography for the Presurgical Evaluation of Patients with Non-lesional Intractable Partial Epilepsy: Comparison among 18F-FDG, 11C-Flumazenil, and 11C-Flumazenil Binding Potential Imaging Using Statistical Imaging Analysis.
Komoto D; Iida K; Higaki T; Kaichi Y; Takauchi K; Arihiro K; Kakita A; Hirokawa Y; Awai K
Hiroshima J Med Sci; 2015 Dec; 64(4):51-7. PubMed ID: 26964154
[TBL] [Abstract][Full Text] [Related]
16. [11C]Flumazenil PET in patients with epilepsy with dual pathology.
Juhász C; Nagy F; Muzik O; Watson C; Shah J; Chugani HT
Epilepsia; 1999 May; 40(5):566-74. PubMed ID: 10386525
[TBL] [Abstract][Full Text] [Related]
17. [11C]flumazenil PET: activity images versus parametric images for the detection of neocortical epileptic foci.
Niimura K; Muzik O; Chugani DC; Shen C; Chugani HT
J Nucl Med; 1999 Dec; 40(12):1985-91. PubMed ID: 10616875
[TBL] [Abstract][Full Text] [Related]
18. Qualitative and quantitative imaging of the hippocampus in mesial temporal lobe epilepsy with hippocampal sclerosis.
Van Paesschen W
Neuroimaging Clin N Am; 2004 Aug; 14(3):373-400, vii. PubMed ID: 15324854
[TBL] [Abstract][Full Text] [Related]
19. In vivo measurement of hippocampal GABAA/cBZR density with [18F]-flumazenil PET for the study of disease progression in an animal model of temporal lobe epilepsy.
Vivash L; Gregoire MC; Bouilleret V; Berard A; Wimberley C; Binns D; Roselt P; Katsifis A; Myers DE; Hicks RJ; O'Brien TJ; Dedeurwaerdere S
PLoS One; 2014; 9(1):e86722. PubMed ID: 24466212
[TBL] [Abstract][Full Text] [Related]
20. PET imaging of brain 5-HT1A receptors in the preoperative evaluation of temporal lobe epilepsy.
Didelot A; Ryvlin P; Lothe A; Merlet I; Hammers A; Mauguière F
Brain; 2008 Oct; 131(Pt 10):2751-64. PubMed ID: 18790822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
